Boscogen Inc
FEI 1000519929 · 8 Chrysler, Irvine, California, 92618, United States
Per FDA, as of 2026-10-31 · Sources: FDA Data Dashboard, Import Alerts, Enforcement Reports
Get a dated evidence report for this supplierFree · for your supplier file · sample
Import alerts
0
Import refusals (5 years)
0
Warning letters
0
Last FDA action
2026-04-21
6 months ago
FDA record
- 2026-04-21InspectionFDA inspection · Classification: Voluntary Action Indicated (VAI)Project area: Food Composition, Standards, Labeling and EconFDA source
- 2019-09-30InspectionFDA inspection · Classification: Voluntary Action Indicated (VAI)Project area: Food Composition, Standards, Labeling and EconFDA source
- 2016-05-26InspectionFDA inspection · Classification: No Action Indicated (NAI)Project area: Foodborne Biological HazardsFDA source
- 2007-06-11RecallRecall F-465-7 · Class 1 · Testing performed recently at NBTY, Inc. (the manufacturer) shows that the recalled capsules have the potential to be contaminated with Salmonella. Although multiple lot numbers may have been involved in the recall by NBTY, only NBTY lot number 64951 was purchased, repacked and distributed by Boscogen, Inc as Lynae Shark Cartilage 750mg, Lot Number FJ04101F, Expiration Date 12/2008.Lynae Shark Cartilage 750mg Capsules, Product Number FS1001, Lot Number FJ04101F, Expiration Date 12/2008, UPC Number 85714 00282 2, 100 capsules per bottleSource: FDA Enforcement Reports